跳至主要内容
临床试验/EUCTR2013-003464-31-GB
EUCTR2013-003464-31-GB进行中(未招募)1 期

A Single-blinded, Randomized, Controlled, Comparative Phase III StudyEvaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patchas an Adjunct to Hemostasis During Cardiovascular Surgery

Ethicon Inc0 个研究点目标入组 210 人开始时间: 2013年11月26日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Ethicon Inc
入组人数
210

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Pre-Operative
  • 1. Subjects =18 years of age, requiring an elective or urgent, open aortic
  • surgical procedure utilizing cardiopulmonary bypass;
  • 2. Subjects must be willing to participate in the study and provide written
  • informed consent.
  • Intra-Operative
  • 1. Presence of an appropriate Target Bleeding Site along the anastomotic
  • suture line, involving a synthetic aortic graft, as identified intraoperatively
  • by the investigator;
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 75
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 75

排除标准

  • Pre-Operative
  • 1. Subjects with known intolerance to blood products or to one of the
  • components of the study product or unwilling to receive blood
  • 2. Exposure to another investigational drug or device in a clinical trial
  • within 30 days prior to surgery or anticipated in the 60 day follow up
  • period after surgery.
  • 3. Female subjects who are pregnant or nursing.
  • Intra-Operative
  • 1. TBS is from a large defects in visible arteries or veins where the injured
  • vascular wall requires repair and maintenance of vessel patency or
  • where there would be persistent exposure of EVARREST™ Fibrin Sealant
  • Patch to blood flow and/or pressure during absorption of the product;
  • 2. TBS with major arterial bleeding requiring suture or mechanical ligation;
  • 3. TBS involves an expanded polytetrafluoroethylene (ePTFE) graft
  • 4. TBS within an actively infected field;
  • 5. Bleeding site is in, around, or in proximity to foramina in bone, or areas
  • of bony confine;
  • 6. Subjects with any intra-operative findings identified by the investigator
  • that may preclude conduct of the study procedure;

研究者

发起方
Ethicon Inc

相似试验